Dr Elliott David Hudson, DPM | |
300 University Blvd Bldg A, Round Rock, TX 78665-1032 | |
(512) 509-0254 | |
Not Available |
Full Name | Dr Elliott David Hudson |
---|---|
Gender | Male |
Speciality | Podiatry |
Experience | 23 Years |
Location | 300 University Blvd Bldg A, Round Rock, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336177005 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213ES0103X | Podiatrist - Foot & Ankle Surgery | 1777 (Texas) | Secondary |
213E00000X | Podiatrist | 1777 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Baylor Scott & White Medical Center - Round Rock | Round rock, TX | Hospital |
Baylor Scott & White Medical Center - Taylor | Taylor, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Scott And White Clinic | 8123923604 | 2131 |
News Archive
Having a faulty gene linked to dementia doubles the risk of developing severe COVID-19, according to a large-scale study.
Scientists have developed a new chimeric antibody that suppresses malignant cancers in dogs, showing promise for safe and effective treatment of intractable cancers.
Researchers at the University at Buffalo have identified two components of saliva that may serve as the basis for novel tests to determine the risk for future loss of the bone that holds teeth in place.
Amorfix Life Sciences, a company focused on misfolded protein diseases, today reported its second quarter operating results and provided an update on the Company's diagnostic and therapeutic programs.
QRxPharma announced today the release of additional pivotal Phase 3 trial data for MoxDuo IR, an immediate-release Dual-Opioid pain therapy. Required for New Drug Application submission with the United States Food and Drug Administration, this "combination rule" study compared the efficacy and safety profiles of MoxDuo IR against component doses of morphine and oxycodone alone for the management of moderate to severe post-operative pain following bunionectomy surgery.
› Verified 3 days ago
Provider Name | Scott & White Clinic |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1093779704 PECOS PAC ID: 8123923604 Enrollment ID: O20031223000640 |
News Archive
Having a faulty gene linked to dementia doubles the risk of developing severe COVID-19, according to a large-scale study.
Scientists have developed a new chimeric antibody that suppresses malignant cancers in dogs, showing promise for safe and effective treatment of intractable cancers.
Researchers at the University at Buffalo have identified two components of saliva that may serve as the basis for novel tests to determine the risk for future loss of the bone that holds teeth in place.
Amorfix Life Sciences, a company focused on misfolded protein diseases, today reported its second quarter operating results and provided an update on the Company's diagnostic and therapeutic programs.
QRxPharma announced today the release of additional pivotal Phase 3 trial data for MoxDuo IR, an immediate-release Dual-Opioid pain therapy. Required for New Drug Application submission with the United States Food and Drug Administration, this "combination rule" study compared the efficacy and safety profiles of MoxDuo IR against component doses of morphine and oxycodone alone for the management of moderate to severe post-operative pain following bunionectomy surgery.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Elliott David Hudson, DPM Po Box 844658, Dallas, TX 75284-1032 Ph: (254) 724-2111 | Dr Elliott David Hudson, DPM 300 University Blvd Bldg A, Round Rock, TX 78665-1032 Ph: (512) 509-0254 |
News Archive
Having a faulty gene linked to dementia doubles the risk of developing severe COVID-19, according to a large-scale study.
Scientists have developed a new chimeric antibody that suppresses malignant cancers in dogs, showing promise for safe and effective treatment of intractable cancers.
Researchers at the University at Buffalo have identified two components of saliva that may serve as the basis for novel tests to determine the risk for future loss of the bone that holds teeth in place.
Amorfix Life Sciences, a company focused on misfolded protein diseases, today reported its second quarter operating results and provided an update on the Company's diagnostic and therapeutic programs.
QRxPharma announced today the release of additional pivotal Phase 3 trial data for MoxDuo IR, an immediate-release Dual-Opioid pain therapy. Required for New Drug Application submission with the United States Food and Drug Administration, this "combination rule" study compared the efficacy and safety profiles of MoxDuo IR against component doses of morphine and oxycodone alone for the management of moderate to severe post-operative pain following bunionectomy surgery.
› Verified 3 days ago
Foot And Shoe, Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 7700 Cat Hollow Dr Ste 102, Round Rock, TX 78681 Phone: 512-733-8600 Fax: 512-733-8602 | |
Dr. Kory Don Williams, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 302 University Blvd, Round Rock, TX 78665 Phone: 512-509-0203 | |
Foot Associates Of Central Texas, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 7700 Cat Hollow Drive, Suite 102, Round Rock, TX 78681 Phone: 512-733-8600 Fax: 512-733-8602 | |
Dr. Amanda Willrich Hudson, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 300 University Blvd Bldg A, Round Rock, TX 78665 Phone: 512-509-0200 Fax: 512-509-0253 | |
Brenda K Cohen, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 7200 Wyoming Spgs Ste 1150, Round Rock, TX 78681 Phone: 512-255-0125 Fax: 512-255-0153 | |
Prakash Panchani, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2681 Gattis School Rd Ste 220, Round Rock, TX 78664 Phone: 512-843-0770 Fax: 512-843-0648 |